☆ 4.7 Letter

Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure Reply

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure The TRANSFORM-HF Randomized Clinical Trial

Robert J. Mentz et al.

Summary: A randomized trial found that torsemide did not result in a significant difference in all-cause mortality compared with furosemide among patients hospitalized for heart failure. However, the interpretation of these findings is limited by loss to follow-up and participant crossover and nonadherence.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

Paul A. Heidenreich et al.

Summary: The 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure provides patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. It is based on contemporary evidence and aims to improve quality of care and align with patients' interests.

JOURNAL OF CARDIAC FAILURE (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Pragmatic Design of Randomized Clinical Trials for Heart Failure Rationale and Design of the TRANSFORM-HF Trial

Stephen J. Greene et al.

Summary: Randomized clinical trials in heart failure populations have faced challenges like slow patient enrollment and high costs. The traditional model for HF trials is difficult to execute in the United States, leading to modest US representation in global trials. The TRANSFORM-HF trial aims to compare the effects of torsemide versus furosemide among HF patients in the US.

JACC-HEART FAILURE (2021)

添加到收藏夹

Article Medicine, General & Internal

Cytochrome P-450 Polymorphisms and Response to Clopidogrel.

Jessica L. Mega et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure Reply

相关参考文献

Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure The TRANSFORM-HF Randomized Clinical Trial

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

Pragmatic Design of Randomized Clinical Trials for Heart Failure Rationale and Design of the TRANSFORM-HF Trial

Cytochrome P-450 Polymorphisms and Response to Clopidogrel.

导出引文

分享论文